Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis

• 作 者: YukikoSaitou KatsuyaShiraki Yu
• 机 构: FirstDepartmentofInternalMedicine
• 出 处: 世界胃肠病学杂志：英文版（电子版）
• 发表日期: 2005年4期
• 关键词: HA HCV IFN AUC ROC PⅢP RIA AIM HCV Liver fibrosis YKL-40 Interferon

AIM: To evaluate the clinical utility of serum fibrosis markers,including YKL-40, in patients with HCV-associated liver disease.METHODS: A total of 109 patients with HCV-associated liver disease were enrolled. We measured serum type Ⅳ collagen, amino-term